From: The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk
Number | Age | Gender | Cancer type | Race | Gene | Protein change | Annotation | Allele freqency in population | OR | 95% CI | Adjusted P |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 28 | MALE | BLCA | WHITE | ATM | p.E1978* | Pathogenic | 0.00004379(11/251182) | 111.38 | 24.61 to 504.09 | 1.33405E−23 |
2 | 26 | FEMALE | BLCA | BLACK OR AFRICAN AMERICAN | ATM | p.M1I | Pathogenic | 0.00000398(1/251388) | 611.65 | 38.19 to 9795.74 | 9.95953E−18 |
3 | 46 | FEMALE | BLCA | WHITE | ATM | p.R2832C | Pathogenic | 0.00003184(8/251268) | 76.42 | 9.54 to 612.38 | 7.13507E−05 |
4 | 60 | FEMALE | BLCA | WHITE | BLM | p.G952V | Pathogenic | 0.00000398(1/251446) | 611.79 | 38.20 to 9798.00 | 9.95953E−18 |
5 | 37 | MALE | BLCA | WHITE | BLM | p.R899* | Pathogenic | 0.00006365(18/282794) | 38.22 | 5.09 to 287.00 | 0.004715125 |
6 | 60 | MALE | BLCA | WHITE | BRCA1 | p.S819X | Pathogenic | 0.00001196(3/250740) | 203.36 | 21.11 to 1959.09 | 1.81953E−09 |
7 | 49 | MALE | BLCA | ASIAN | BRCA2 | p.R2494* | Pathogenic | 0.00003182(8/251440) | 76.47 | 9.54 to 612.80 | 7.13507E−05 |
8 | 50 | FEMALE | BLCA | WHITE | CHEK2 | p.S471F | Pathogenic | 0.00046420(131/282204) | 15.79 | 5.01 to 49.81 | 2.63664E−07 |
9 | 58 | FEMALE | BLCA | WHITE | CHEK2 | p.S471F | Pathogenic | 0.00046420(131/282204) | 15.79 | 5.01 to 49.81 | 2.63664E−07 |
10 | 59 | MALE | BLCA | WHITE | CHEK2 | p.W93* | Pathogenic | 0.00002388(6/251270) | 101.89 | 12.24 to 848.24 | 5.9444E−06 |
11 | 43 | MALE | BLCA | WHITE | FANCG | p.E105* | Pathogenic | 0.00001425(4/280654) | 170.71 | 19.04 to 1530.66 | 1.32534E−08 |
12 | 66 | MALE | BLCA | WHITE | NBN | p.KQ233-234X | Pathogenic | 0.00001999(5/250094) | 121.70 | 14.19 to 1043.98 | 1.08043E−06 |
13 | 63 | FEMALE | BLCA | WHITE | NF1 | p.R1362* | Pathogenic | 0.00000398(1/251344) | 611.54 | 38.18 to 9794.02 | 9.95953E−18 |
14 | 53 | FEMALE | BLCA | WHITE | PALB2 | p.R753* | Pathogenic | 0.00002386(6/251486) | 101.98 | 12.25 to 848.97 | 5.9444E−06 |
15 | 65 | MALE | BLCA | WHITE | RAD50 | p.R1077* | Pathogenic | 0.00002123(6/282600) | 114.60 | 13.77 to 954.00 | 1.54259E−06 |
16 | 40 | MALE | BLCA | WHITE | SERPINA1 | p.Y184* | Pathogenic | 0.00017670(50/282896) | 27.59 | 6.69 to 113.79 | 3.14159E−07 |
17 | 48 | MALE | BLCA | WHITE | VHL | p.L188V | Pathogenic | 0.00002121(6/282824) | 114.69 | 13.78 to 954.76 | 1.54259E−06 |
18 | 52 | MALE | KICH | WHITE | CHEK2 | p.S471F | Pathogenic | 0.00046420(131/282204) | 102.53 | 31.80 to 330.64 | 2.62808E−43 |
19 | 11 | FEMALE | KICH | WHITE | NF1 | p.K1444E | Pathogenic | NA | NA | NA | NA |
20 | 37 | FEMALE | KIRC | WHITE | BAP1 | p.Q684* | Pathogenic | 0.00000398(1/251330) | 1305.61 | 118.14 to 14,429.10 | 1.3624E−106 |
21 | 41 | FEMALE | KIRC | BLACK OR AFRICAN AMERICAN | BAP1 | p.Q684* | Pathogenic | 0.00000398(1/251330) | 1305.61 | 118.14 to 14,429.10 | 1.3624E−106 |
22 | 60 | FEMALE | KIRC | WHITE | BLM | p.Q548* | Pathogenic | 0.00016650(46/276228) | 15.55 | 2.14 to 113.07 | 0.091089752 |
23 | 48 | FEMALE | KIRC | WHITE | BRCA1 | p.T1119 | Pathogenic | 0.00000400(1/250270) | 648.37 | 40.48 to 10,384.92 | 1.16019E−18 |
24 | 55 | MALE | KIRC | WHITE | FAH | p.P261L | Pathogenic | 0.00015910(45/282876) | 16.28 | 2.24 to 118.42 | 0.082722898 |
25 | 41 | MALE | KIRC | WHITE | GJB2 | p.KFIKG105-109X | Pathogenic | NA | NA | NA | NA |
26 | 45 | FEMALE | KIRC | WHITE | GJB2 | p.Q57* | Pathogenic | 0.00003187(9/282412) | 81.29 | 10.27 to 643.20 | 3.73735E−05 |
27 | 47 | FEMALE | KIRC | WHITE | MUTYH | p.R242H | Pathogenic | 0.00008521(24/281670) | 30.40 | 4.10 to 225.30 | 0.012249846 |
28 | 34 | FEMALE | KIRC | BLACK OR AFRICAN AMERICAN | PMS2 | p.LT731-732X | Pathogenic | NA | NA | NA | NA |
29 | 29 | MALE | KIRC | WHITE | TP53 | p.H365Y | Pathogenic | NA | NA | NA | NA |
30 | 23 | FEMALE | KIRC | BLACK OR AFRICAN AMERICAN | VHL | p.C162F | Pathogenic | 0.00000398(1/251440) | 1306.18 | 118.19 to 14,435.42 | 1.3624E−106 |
31 | 38 | FEMALE | KIRC | BLACK OR AFRICAN AMERICAN | VHL | p.C162F | Pathogenic | 0.00000398(1/251440) | 1306.18 | 118.19 to 14,435.42 | 1.3624E−106 |
32 | 50 | FEMALE | KIRC | WHITE | VHL | p.R167W | Pathogenic | 0.00000795(2/251448) | 325.71 | 29.47 to 3599.59 | 5.93449E−13 |
33 | 29 | FEMALE | KIRC | WHITE | XPC | p.V548X | Pathogenic | 0.00002005(5/249358) | 129.20 | 15.06 to 1108.48 | 5.01842E−07 |
34 | 33 | MALE | KIRP | WHITE | ATM | p.R1875* | Pathogenic | 0.00002002(5/249754) | 173.44 | 20.20 to 1489.20 | 5.08026E−09 |
35 | 57 | MALE | KIRP | WHITE | BRCA2 | p.Q3066* | Pathogenic | NA | NA | NA | NA |
36 | 47 | MALE | KIRP | BLACK OR AFRICAN AMERICAN | FAH | p.G337S | Pathogenic | 0.00007501(21/279946) | 46.28 | 6.20 to 345.24 | 0.001643527 |
37 | 18 | FEMALE | KIRP | BLACK OR AFRICAN AMERICAN | FH | p.S187* | Pathogenic | 0.00000399(1/250648) | 870.30 | 54.30 to 13,948.21 | 1.42543E−24 |
38 | 52 | MALE | KIRP | WHITE | GJB2 | p.E47* | Pathogenic | 0.00000399(1/250772) | 870.73 | 54.33 to 13,955.12 | 1.42543E−24 |
39 | 38 | MALE | KIRP | WHITE | MET | p.H1112R | Pathogenic | 0.00001203(3/249346) | 871.83 | 175.22 to 4337.80 | 1.476E−195 |
40 | 35 | MALE | KIRP | WHITE | MET | p.H1112R | Pathogenic | 0.00001203(3/249346) | 871.83 | 175.22 to 4337.80 | 1.476E−195 |
41 | 30 | FEMALE | KIRP | WHITE | MET | p.H1112R | Pathogenic | 0.00001203(3/249346) | 871.83 | 175.22 to 4337.80 | 1.476E−195 |
42 | 37 | MALE | KIRP | WHITE | MUTYH | p.E407GX | Pathogenic | 0.00014170(40/282334) | 49.18 | 11.83 to 204.46 | 3.90416E−12 |
43 | 57 | MALE | KIRP | WHITE | MUTYH | p.E407GX | Pathogenic | 0.00014170(40/282334) | 49.18 | 11.83 to 204.46 | 3.90416E−12 |
44 | 62 | MALE | KIRP | WHITE | PMS2 | p.M1T | Pathogenic | 0.00000400(1/250260) | 868.95 | 54.22 to 13,926.62 | 1.48087E−24 |
45 | 43 | MALE | KIRP | BLACK OR AFRICAN AMERICAN | RET | p.D631Y | Pathogenic | 0.00000405(1/246932) | 857.40 | 53.50 to 13,741.42 | 2.80654E−24 |
46 | 38 | MALE | PRAD | [Unknown] | ATM | c.2921 + 1 N > A | Pathogenic | 0.00002388(6/251304) | 84.27 | 10.13 to 701.29 | 4.10188E−05 |
47 | 53 | MALE | PRAD | WHITE | ATM | p.E1978* | Pathogenic | 0.00004379(11/251182) | 92.07 | 20.36 to 416.46 | 1.22898E−19 |
48 | 38 | MALE | PRAD | [Unknown] | ATM | p.R3008C | Pathogenic | 0.00001591(4/251428) | 126.47 | 14.11 to 1133.57 | 1.08043E−06 |
49 | 51 | MALE | PRAD | [Unknown] | ATM | p.R447* | Pathogenic | 0.00000796(2/251290) | 252.80 | 22.89 to 2792.61 | 2.47305E−10 |
50 | 49 | MALE | PRAD | WHITE | BRCA1 | p.Q1408* | Pathogenic | 0.00000398(1/251400) | 505.83 | 31.59 to 8098.72 | 6.97237E−15 |
51 | 38 | MALE | PRAD | [Unknown] | BRCA1 | p.R1772* | Pathogenic | 0.00001414(4/282892) | 142.30 | 15.88 to 1275.42 | 2.40779E−07 |
52 | 41 | MALE | PRAD | [Unknown] | BRCA1 | p.VN923-924X | Pathogenic | 0.00000398(1/251024) | 505.08 | 31.55 to 8086.61 | 7.07023E−15 |
53 | 40 | MALE | PRAD | [Unknown] | BRIP1 | p.V758VX | Pathogenic | 0.00000796(2/251216) | 252.73 | 22.88 to 2791.78 | 2.47305E−10 |
54 | 53 | MALE | PRAD | [Unknown] | DKC1 | p.S280R | Pathogenic | 0.00027780(57/205151) | 7.24 | 1.00 to 52.39 | 0.33671376 |
55 | 41 | MALE | PRAD | [Unknown] | GALNT3 | c.516-2A > T | Pathogenic | 0.00003897(11/282266) | 51.63 | 6.65 to 400.66 | 0.001068325 |
56 | 36 | MALE | PRAD | [Unknown] | PALB2 | p.P684X | Pathogenic | 0.00000795(2/251460) | 252.98 | 22.90 to 2794.49 | 2.47305E−10 |
57 | 44 | MALE | PRAD | [Unknown] | PMS2 | c.989-1G > T | Pathogenic | 0.00000405(1/246764) | 496.51 | 31.01 to 7949.38 | 1.18724E−14 |
58 | 41 | MALE | PRAD | [Unknown] | RAD51C | p.R237* | Pathogenic | 0.00001591(4/251374) | 126.44 | 14.11 to 1133.32 | 1.08043E−06 |
59 | 44 | MALE | PRAD | [Unknown] | SERPINA1 | p.Y184* | Pathogenic | 0.00017670(50/282896) | 22.81 | 5.53 to 94.00 | 3.82838E−06 |
 |  |  |  |  |  |  | Overall | 0.00345284(938/271661) | 14.88 | 11.80 to 18.77 | 2.2E−16 |